LOS ANGELES and STAMFORD, Conn., RSNA Annual Meeting, Nov. 28 /PRNewswire-FirstCall/ -- CompuMed, Inc. -- a developer of Computer Aided Diagnostic (CAD) solutions for the healthcare industry -- and FUJIFILM Medical Systems USA, Inc. (Div. Fuji Photo Film Co., Ltd.) today announced the signing of a licensing agreement that enables FUJIFILM Medical Systems USA, Inc. (Fuji) to integrate CompuMed’s proprietary OsteoGram(R) osteoporosis screening software with its market-leading computed radiography (CR) systems, as well as future CR mammography systems*.
Under the terms of the five year agreement, Fuji will place an initial order for 10 OsteoGram systems and then license and distribute the OsteoGram on existing and new CR systems, as well as future mammography platforms in the United States. Fuji has the largest installed base of CR systems in the U.S., and currently markets its products through a direct sales organization and a nationwide network of imaging distributors.
“We are proud to partner with Fuji -- the global leader in digital x-ray systems,” said Jerry McLaughlin, chief executive officer of CompuMed. “Our OsteoGram application complements Fuji’s marketing strategies, and will add significant value to their industry-leading offerings in the orthopedic, CR mammography and general radiology arenas.”
The OsteoGram is a medical image processing system that enables healthcare providers to screen, diagnose and monitor osteoporosis using digital images from filmless x-ray equipment or conventional, film-based hand x-rays. The system analyzes such images via proprietary software that produces a bone mineral density (BMD) report. The OsteoGram is far less costly and cumbersome than conventional hardware-based BMD systems, which require dedicated and expensive equipment, computers, office space and staff. According to the International Osteoporosis Foundation (IOF), osteoporosis affects more than 200 million people worldwide, 80 percent of whom are women. The disease poses a major public health threat for 44 million Americans, and costs the U.S. healthcare system in excess of $17 billion annually.
“Integrating CompuMed’s unique OsteoGram system with Fuji’s computed radiology equipment will enable women to get screened for osteoporosis at the same time they undergo a mammogram or other common medical imaging exam,” said John Strauss, Fuji’s director of marketing for imaging systems. “We believe integrating these systems will serve an important public health need by making osteoporosis screening more convenient for patients, while also helping healthcare providers add services and improve workflow.”
OsteoGram-enhanced Fuji CR systems will be showcased at the 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago (November 27-December 2). They will be on display with Fuji’s family of computed radiography systems at the Fuji exhibit (McCormick Place North Building -- Hall B Booth: 7157).
About RSNA
The Radiological Society of North America (RSNA) is an association of more than 33,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in patient care. Its Scientific Assembly and Annual Meeting in Chicago (November 27-December 2) comprise the world’s largest medical imaging exhibition, featuring more than 600 leading manufacturers, suppliers and developers of radiology products and services. Visit RSNA at www.rsna.org.
About CompuMed
Founded in 1973, CompuMed, Inc. is a leading provider of computer-aided telemedicine and diagnostics technology. The company’s core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net.
About FUJIFILM Medical
FUJIFILM Medical is a leading provider of medical image and information products and technologies for acquiring, processing, presenting, managing and storing diagnostic images. As the diagnostic imaging market continues its transformation from film-based to digitally driven, Fuji’s full suite of innovative, high quality products -- like Synapse PACS and Fuji Computed Radiography (FCR) digital x-ray reader -- are helping to lead the way. Fuji has the experience, technology and vision to successfully lead its customers in the challenging healthcare environment of the future. Visit Fuji at www.fujimed.com.
This news release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, availability of appropriate acquisition candidates and/or business partnerships, economic conditions, impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks described in our filings with the Securities and Exchange Commission. All forward-looking statements whether made by or on behalf of the Companies are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
* Fuji CR for Mammography (FCRm) requires FDA approval, is pending PMA review and is not yet commercially available in the U.S.
CompuMed, Inc.
CONTACT: Erik Deutsch of Tellem Worldwide, +1-310-479-6111, ext.15, orcell, +1-310-597-9245, edeutsch@tellem.com, for CompuMed, Inc.
